SCHEMBL2965771

SCHEMBL2965771

CC(Br)c1[c]c2c(cc1)-c1ccccc1C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
CYP17A1 P05093 1/20 0.33
MAOA P21397 2/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
ADRA2A P08913 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2975201 0.87 CYP1A2 (0.37) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL617020 0.87 CYP1A2 (0.37) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL2973834 0.83 CYP1A2 (0.39) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL3058003 0.81 CYP1A2 (0.37) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL2957703 0.81 CYP1A2 (0.37) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL18242620 0.74 ALDH1A1 (0.40) CYP1A2CYP3A4CYP2C9ALDH1A1MAPT
SCHEMBL216980 0.74 ALDH1A1 (0.40) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL2478927 0.74 RAB9A (0.40) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL2960382 0.73 ALDH1A1 (0.37) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9
SCHEMBL4719922 0.73 MALT1 (0.35) CYP1A2CYP3A4HSD17B10CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 CYP1A2 2409/4885CYP3A4 1385/4885HSD17B10 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.